ArticleFrontiers in medicine2026
Distinct trajectories of low anterior resection syndrome following ileostomy reversal.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study is an midterm postoperative assessment of LARS symptoms, aiming to apply group-based trajectory modeling to analyze the symptom trajectories of low anterior resection syndrome in rectal cancer patients who underwent ileostomy and subsequent reversal, and to investigate the clinical and treatment-related factors influencing these trajectories. Methods: A retrospective cohort of 134 rectal cancer patients who underwent low anterior resection with diverting ileostomy and subsequent reversal was analyzed. LARS scores were recorded at 3, 6, 9, and 12 months postoperatively. GBTM was used to classify patients into symptom trajectory groups. Multinomial logistic regression identified clinical factors associated with each trajectory. Results: Among 134 rectal cancer patients included, group-based trajectory modeling identified three LARS symptom trajectories following stoma reversal: mild and recovering (30.6%), moderate and fluctuating (40.3%), and severe and persistent (29.1%). Over the 12-months follow-up, LARS scores declined overall, with significant differences in symptom severity observed among the three groups at all time points ( Conclusion: Preoperative radiotherapy, low anastomotic height, and advanced tumor stage significantly increase the probability of following a severe and persistent LARS trajectory. Recognizing these factors as probabilistic risks rather than absolute determinants may facilitate early tailored interventions and enhance personalized postoperative recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.